- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06487741
Efficacy of a Home-based Stretching Program on Fibromyalgia Symptoms: a Randomised Controlled Trial
February 12, 2025 updated by: University College of Northern Denmark
This randomised controlled trial will examine the clinical efficacy of a six-week, novel, home-based stretching programme compared to usual care on the effect of symptoms experienced by patients with fibromyalgia.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
58
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Allan Riis, PT. Ph.D.
- Phone Number: +4572691310
- Email: alr@ucn.dk
Study Contact Backup
- Name: Morten P Støve, PT. Msc.
- Phone Number: 72691004
- Email: mps@ucn.dk
Study Locations
-
-
-
Aalborg, Denmark, 9220
- Recruiting
- University College of Northern Denmark
-
Contact:
- Morten P Støve, PT, Msc.
- Phone Number: 004522980862
- Email: mps@ucn.dk
-
Principal Investigator:
- Morten P Støve, PT, Msc.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- individuals diagnosed with fibromyalgia in accordance with the ACR 2016 diagnostic criteria.
- individuals diagnosed with chronic non-malignant pain or individuals diagnosed with chronic widespread pain (including fibromyalgia syndrome) are also included when they meet the ACR 2016 diagnostic criteria.
Exclusion Criteria:
- Non-controlled systemic disorders (such as hypertension, diabetes and coronary insufficiency),
- neurological conditions that impair alertness or comprehension, musculoskeletal conditions that could compromise assessments (such as nerve root compression or knee joint inflammation),
- relevant joint disorders (such as severe arthritis, arthroplasty of the hip or knee, and rheumatoid arthritis),
- recent changes in therapy for fibromyalgia (i.e., within four weeks of baseline).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
The intervention group receives a home-based rehabilitation program consisting of six weeks of daily static stretching exercises (six minutes a day).
|
The intervention comprises six weeks of daily static stretching exercises (six minutes a day) in accordance with the recommendation of the American College of Sports Medicine.
The intervention is self-administered and consists of two bouts of 30-second bilateral static stretches of the knee flexors, hip abductors, and shoulder elevators.
|
|
No Intervention: Control
The control group receives usual care, and no change in treatment is made.
Participants will be encouraged to maintain their daily routine but refrain from changing the current pharmacological treatment or initiating new physical exercise practices during the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Severity of symptoms
Time Frame: Measured at baseline
|
The Revised Fibromyalgia Impact Questionnaire (FIQ-R) total score
|
Measured at baseline
|
|
Severity of symptoms
Time Frame: Measured following 6 weeks of intervention (primary endpoint)
|
The Revised Fibromyalgia Impact Questionnaire (FIQ-R) total score
|
Measured following 6 weeks of intervention (primary endpoint)
|
|
Severity of symptoms
Time Frame: Measured 6 months after the primary endpoint (secondary endpoint)
|
The Revised Fibromyalgia Impact Questionnaire (FIQ-R) total score
|
Measured 6 months after the primary endpoint (secondary endpoint)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health-Related Quality of life (HRQL)
Time Frame: Measured at baseline
|
HRQL is assessed using the Danish version of the Short Form-36
|
Measured at baseline
|
|
Health-Related Quality of life (HRQL)
Time Frame: Measured following 6 weeks of intervention (primary endpoint)
|
HRQL is assessed using the Danish version of the Short Form-36
|
Measured following 6 weeks of intervention (primary endpoint)
|
|
Health-Related Quality of life (HRQL)
Time Frame: Measured 6 months after the primary endpoint (secondary endpoint)
|
HRQL is assessed using the Danish version of the Short Form-36
|
Measured 6 months after the primary endpoint (secondary endpoint)
|
|
Self-reported physical activity
Time Frame: Measured at baseline
|
The International Physical Activity Questionnaire (IPAQ) short form
|
Measured at baseline
|
|
Self-reported physical activity
Time Frame: Measured following 6 weeks of intervention (primary endpoint)
|
The International Physical Activity Questionnaire (IPAQ) short form
|
Measured following 6 weeks of intervention (primary endpoint)
|
|
Self-reported physical activity
Time Frame: Measured 6 months after the primary endpoint (secondary endpoint)
|
The International Physical Activity Questionnaire (IPAQ) short form
|
Measured 6 months after the primary endpoint (secondary endpoint)
|
|
Range of motion
Time Frame: Measured at baseline
|
Passive knee extension range of motion is assessed using the Biodex System 4 Pro isokinetic dynamometer
|
Measured at baseline
|
|
Range of motion
Time Frame: Measured following 6 weeks of intervention (primary endpoint)
|
Passive knee extension range of motion is assessed using the Biodex System 4 Pro isokinetic dynamometer
|
Measured following 6 weeks of intervention (primary endpoint)
|
|
Pain sensitivity
Time Frame: Measured at baseline
|
Pain sensitivity expressed as pressure pain thresholds are assessed using a handheld electronic pressure algometer
|
Measured at baseline
|
|
Pain sensitivity
Time Frame: Measured following 6 weeks of intervention (primary endpoint)
|
Pain sensitivity expressed as pressure pain thresholds are assessed using a handheld electronic pressure algometer
|
Measured following 6 weeks of intervention (primary endpoint)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence
Time Frame: Measured following 6 weeks of intervention (primary endpoint)
|
Adherence to the intervention is evaluated by the number of days stretching is performed using the self-reported data from the mHealth app.
|
Measured following 6 weeks of intervention (primary endpoint)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Lise Eckardt, Pt. Msc, Department of Physiotherapy, University College of Northern Denmark
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 31, 2024
Primary Completion (Estimated)
August 30, 2026
Study Completion (Estimated)
August 30, 2026
Study Registration Dates
First Submitted
June 27, 2024
First Submitted That Met QC Criteria
June 27, 2024
First Posted (Actual)
July 5, 2024
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 12, 2025
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Fibromyalgia RCT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The study protocol will be published open access.
Data is made available upon reasonable request.
IPD Sharing Time Frame
The study protocol will be published open access.
IPD Sharing Access Criteria
Data is made available upon request.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
Selcuk UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...CompletedFibromyalgia (FM)Spain
-
Istanbul Gelisim UniversityBahçeşehir UniversityCompleted
-
Gazi UniversityCompletedFibromyalgia SyndromeTurkey (Türkiye)
-
Italian Association for the Research and the Scientific...Not yet recruiting
-
Ionclinics & Deionic SLHospital Clínico Universitario de ValenciaNot yet recruitingFibromyalgia (FM)Spain
-
Ain Shams UniversityRecruiting
-
University of UtahRecruitingFibromyalgia (FM)United States
-
María Catalina Osuna PérezActive, not recruitingFibromyalgia SyndromeSpain
Clinical Trials on Home-based stretching exercises
-
Cairo UniversityPrincess Nourah Bint Abdulrahman UniversityCompleted
-
Baskent UniversityCompletedAging | COVID-19 Pandemic | Physical InactivityTurkey
-
Acibadem UniversityCompletedPhysical Activity | Exercise Addiction | Pediatric Kidney DiseaseTurkey
-
Pamukkale UniversityCompletedFibromyalgia SyndromeTurkey
-
Riphah International UniversityCompletedHome Based Exercises With and Without Posture and Ergonomics Training Among Students During COVID-19Musculoskeletal PainPakistan
-
Riphah International UniversityCompletedMusculoskeletal PainPakistan
-
The University of Hong KongEnrolling by invitationDelirium | Cognitive Function | Post Intensive Care Syndrome | ARDS: Acute Respiratory Distress Syndrome | Loss of Muscle Mass | Loss of Muscle StrengthHong Kong
-
Majmaah UniversityCompletedCerebro-vascular AccidentSaudi Arabia
-
University of SalamancaRecruitingCardiovascular DiseasesSpain
-
Kirsehir Ahi Evran UniversitesiCompletedEfficacy of Home-Based Posture Exercises as an Addition to Pharmacological Treatment in FibromyalgiaFibromyalgiaTurkey (Türkiye)